# 2-LB: Semaglutide 2.4 mg Reduces the 10-Year T2D Risk in People with Overweight/Obesity

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/2-lb-semaglutide-2-4-mg-reduces-the-10-year-t2d-risk-in-people-with-overweight/

## Facts

| Field | Value |
| --- | --- |
| Author Names | W. TIMOTHY GARVEY,Thomas Holst‐Hansen,PETER N. LAURSEN,ANDERS R. RINNOV,LUA J. WILKINSON |
| Citations | 6 |
| DOI | 10.2337/db22-2-lb |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4281944858 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Thomas Holst‐Hansen](https://scholariq.org/researchers/thomas-holst-hansen/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.